Advanced Biomed Inc. (ADVB)

Advanced Biomed Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Net Income	-4.75	-4.03	-1.84
Depreciation & Amortization	0.31	0.13	0.06
Other Operating Activities	-0.23	3.16	1.31
Operating Cash Flow	-4.67	-0.74	-0.47
Capital Expenditures	-0.71	-1.31	-0.03
Acquisitions	-	0.2	-
Other Investing Activities	0.37	0.03	-
Investing Cash Flow	-0.34	-1.08	-0.03
Share Issuance / Repurchase	-	6.1	0.7
Financing Cash Flow	7.1	6.1	0.7
Net Cash Flow	2.24	4.72	0
Free Cash Flow	-5.38	-2.05	-0.5

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).